Fagron Compounding Services recalled 109,320 syringes of bevacizumab (Avastin) on August 29, 2025. The recall follows a lack of assurance of sterility, posing a high health risk. Consumers and healthcare providers should stop using the product immediately.
Lack of Assurance of Sterility
Consumers and healthcare providers should stop using this product immediately. Contact Fagron Compounding Services or your healthcare provider for guidance. Notification method: Letter
The product is bevacizumab (Avastin) Injection, 1.25mg/0.05mL in sterile single-dose syringes. It was distributed nationwide in the USA. The recall includes lot numbers C274-000044756, C274-000044757, and others with expiration dates ranging from September 13, 2025, to September 20, 2025.
The recall was initiated due to a lack of assurance of sterility, which can lead to serious infections or complications. The FDA classified this recall as Class II, indicating a risk of temporary or medically reversible adverse health consequences.
No specific incidents or injuries have been reported related to this recall. The absence of sterility assurance raises concerns for potential infections.
Stop using the recalled product immediately. Consumers should contact Fagron Compounding Services or their healthcare provider for guidance on the next steps.
For more information, contact Fagron Compounding Services. Visit their website or call for assistance.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.